Stock info Exact Sciences Corp | Filter  Basic-Info

Exact Sciences Corp

Exact Sciences Corp's core business is the pharmaceutical sector. Between 2006 and 2016 the global pharmaceutical companies gained around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

The past year was a good investment year for Exact Sciences Corp investors

The stock gained over the past 12 months at around 53 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 86 percent. Exact Sciences Corp's revenues between 2011 and 2015 were very volatile and moved between 4,14 million dollars and 39,44 million dollars. Exact Sciences Corp's net results between 2011 and 2015 were very fluctuating and moved between -28,68 million dollars and -157,8 million dollars.

Over the past 5 years the American company paid out dividends.

Exact Sciences Corp financed with relatively a lot of debt

As per the end of 2015 the American company's balance sheet equaled 364,3 million dollars. At the end of 2015 the total debt positon equaled 37,44 million dollars. This is around 10,28 percent of the total balance sheet. At the end of 2016 the American company was traded with a price/earnings-ratio of around -16. So investors paid -16 times the company's 2015's EPS. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the pharmaceutical company's market size (her number of outstanding share times the stock price) equaled around 793,28 million dollars. At the end of 2015 the American company had around 92,14 million stocks listed on the stock exchange(s).

All the company's financial reports are available here. More information about Exact Sciences Corp can be found it's website. .